Professional-grade financial intelligence

20M+ securities. Real-time data. Institutional insights.

Subscribe for $2

Trusted by professionals at Goldman Sachs, BlackRock, and JPMorgan

Overview
Profile
OraSure Technologies Stock

OraSure Technologies Stock OSUR

OSUR
US68554V1089
881351

Price

0
Today +/-
-0
Today %
-0 %

OraSure Technologies stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the OraSure Technologies stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the OraSure Technologies stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the OraSure Technologies stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze OraSure Technologies's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

OraSure Technologies Stock Price History

DateOraSure Technologies Price
7/25/20250 undefined
7/25/20253.36 undefined
7/24/20253.33 undefined
7/23/20253.31 undefined
7/22/20253.56 undefined
7/21/20253.26 undefined
7/18/20253.21 undefined
7/17/20253.29 undefined
7/16/20253.20 undefined
7/15/20253.11 undefined
7/14/20253.08 undefined
7/11/20253.11 undefined
7/10/20253.06 undefined
7/9/20253.05 undefined
7/8/20253.04 undefined
7/7/20253.06 undefined
7/3/20253.08 undefined
7/2/20253.10 undefined
7/1/20253.02 undefined
6/30/20253.02 undefined
6/27/20253.02 undefined

OraSure Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into OraSure Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by OraSure Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects OraSure Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of OraSure Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into OraSure Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing OraSure Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on OraSure Technologies’s growth potential.

OraSure Technologies Revenue, EBIT and net profit per share

DateOraSure Technologies RevenueOraSure Technologies EBITOraSure Technologies Net Income
2028e163.2 M undefined6.12 M undefined15.94 M undefined
2027e151.11 M undefined0 undefined-33.03 M undefined
2026e139.34 M undefined-48.6 M undefined-44.41 M undefined
2025e130.47 M undefined-63.01 M undefined-56.56 M undefined
2024185.83 M undefined-23.45 M undefined-19.5 M undefined
2023405.47 M undefined47.28 M undefined53.66 M undefined
2022387.5 M undefined-6.1 M undefined-17.9 M undefined
2021233.7 M undefined-11.7 M undefined-23 M undefined
2020171.7 M undefined-4.8 M undefined-14.9 M undefined
2019154.6 M undefined7.8 M undefined16.7 M undefined
2018181.7 M undefined29.6 M undefined20.4 M undefined
2017167.1 M undefined27.7 M undefined30.9 M undefined
2016128.2 M undefined20.3 M undefined19.7 M undefined
2015119.7 M undefined8.1 M undefined8.2 M undefined
2014106.5 M undefined-10.3 M undefined-4.6 M undefined
201398.9 M undefined-20.5 M undefined-11.2 M undefined
201287.8 M undefined-16.3 M undefined-15.1 M undefined
201181.9 M undefined-9.4 M undefined-8.8 M undefined
201075 M undefined-3.4 M undefined-3.5 M undefined
200977 M undefined-4.3 M undefined-7.8 M undefined
200871.1 M undefined-16.3 M undefined-31.3 M undefined
200782.7 M undefined-1.2 M undefined2.5 M undefined
200668.2 M undefined6.1 M undefined5.3 M undefined
200569.4 M undefined7.6 M undefined27.4 M undefined

OraSure Technologies Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
19971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e
2020242832324054696882717775818798106119128167181154171233387405185130139151163
--20.0016.6714.29-25.0035.0027.78-1.4520.59-13.418.45-2.608.007.4112.648.1612.267.5630.478.38-14.9211.0436.2666.094.65-54.32-29.736.928.637.95
60.0060.0058.3360.7162.5059.3860.0057.4159.4264.7160.9857.7561.0462.6762.9663.2259.1862.2667.2368.7559.2862.4361.0459.0650.2137.9842.4742.7060.7756.8352.3248.47
12121417201924314144504147475155586680889911394101117147172790000
-2-2-4-12-3-3-102752-31-7-3-8-15-11-4819302016-14-23-1753-19-56-44-3315
--100.00200.00-75.00--66.67---81.48-60.00-1,650.00-77.42-57.14166.6787.50-26.67-63.64-300.00137.5057.89-33.33-20.00-187.5064.29-26.09-411.76-135.85194.74-21.43-25.00-145.45
26.226.230.63536.937.639.844.546.146.646.946.545.946.246.951.555.655.956.856.56162.562.267.57272.574.3974.430000
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The OraSure Technologies Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the OraSure Technologies is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (k)
INVENTORIES (M)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (M)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (M)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
19992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                   
14.320.115.214.96466.777.69195.682.579.775.723.987.993.297.9101.3119.1154.1156.6156.3209.4153110.8290.41267.76
3.95.36.15.28.27.111.610.411.311.613.712.517.217.51316.119.319.842.534.836.938.845.370.840.1723.82
0200000000000000000000000000
2.41.54.44.1454.15.59.410.78.87.39.612.811.415.813.211.819.322.923.231.953.195.747.6134.2
0.71.110.90.91.28.15.77.61.42.622.2221.42.95.7658.18.847.847.98.277.44
21.328.226.725.177.180101.4112.6123.9106.2104.897.552.9120.2119.6131.2136.7156.4221.9219.3224.5288.9299.2325.2386.46333.22
5.26.77.87.46.55.65.817.420.921.22019.619.918.517.917.920.12021.424.337.357.68571.158.2758.69
00000000000000000020.744.833.447.7170028.3
00000000000000000000000000
2.62.422.51.92.12.96.35.34.40.84.830.427.222.217.512.610.38.25.114.717.914.311.71.2117.44
00000000000024.725.423.821.718.318.820.118.536.240.440.335.135.740.33
0.50.50.60.60.60.520.620.317.40.11.30.600.10.71.21.72.33.93.63.225.11.11.221.68
8.39.610.410.598.229.34443.625.722.1257571.264.658.352.751.474.396.3124.8165.6161.711996.39146.44
29.637.837.135.686.188.2130.7156.6167.5131.9126.9122.5127.9191.4184.2189.5189.4207.8296.2315.6349.3454.5460.9444.2482.84479.66
                                                   
00000000000000000000000000
128.1148.8152.8155.6204.9209.9226.2228.1236.3235.9239.1241.7249.6333.5338.7344.9345.3350.5387.9401.3401.8505.1511.1520.4529.54538.13
-109.6-122.4-126.1-129.4-130.6-131.1-103.7-98.4-96-127.3-135.1-138.6-147.4-162.5-173.7-178.3-170.2-150.5-119.5-99.2-82.5-97.5-120.5-137.6-83.93-103.43
-0.3-0.2-0.1-0.2-0.8-3.2-3.6-0.2-0.200-0.2-2-0.7-3.8-7.8-15.6-14.2-10.3-18.7-12.1-8.7-9.6-18.2-14.94-24.36
000000000-0.3-0.20000000000-0.3-0.4-0.200
18.226.226.62673.575.6118.9129.5140.1108.3103.8102.9100.2170.3161.2158.8159.5185.8258.1283.4307.2398.6380.6364.4430.67410.34
1.22.12.91.83.52.42.53.35.63.93.42.94.13.44.87.15.14.610.210.69.617.4283813.158.17
2.62.72.734.76.26.410.89.28.89.97.79.27.81311.110.411.314.212.415.323.43627.524.2922.31
0.20.70.40.30.71.41.31.92.821.61.31.35.51.18.29.71.47.857.25.23.12.31.562.96
00000000000000000000000000
1.11.11.11.11.11.10.50.60.60.60.57.87.300000000.60.50.91.20.540.04
5.16.67.16.21011.110.716.618.215.315.419.721.916.718.926.425.217.332.22832.746.5686939.5433.48
5.84.63.63.42.51.30.9108.88.37.80000000001.40.920.50.230.11
0000000000005.64.43.43.22.92.420.90.91.22.20.40.550
0.50.20.10.10.20.10.20.50.300000.10.71.21.82.33.93.37.27.38.29.811.8635.73
6.34.83.73.52.71.41.110.59.18.37.805.64.54.14.44.74.75.94.29.59.412.410.712.6435.84
11.411.410.89.712.712.511.827.127.323.623.219.727.521.22330.829.92238.132.242.255.980.479.752.1769.32
29.637.637.435.786.288.1130.7156.6167.4131.9127122.6127.7191.5184.2189.6189.4207.8296.2315.6349.4454.5461444.1482.84479.66
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of OraSure Technologies provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand OraSure Technologies's financial health and stability.

Assets

OraSure Technologies's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that OraSure Technologies must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of OraSure Technologies after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into OraSure Technologies's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (M)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
1997199819991999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
-2-2-40-12-3-3-102752-31-7-3-8-15-11-4819302016-14-23-1753
1110222222123334766556679111520
000000000-183122000-1000000-101-10
00000-4000-500-4-21-3-180-4-6-15-2-94-38-7045
00101010137513106910111112121430014213931
0000000000000000000000000000
000000000000000000001417109139-4
-1-100-10-5023101611-203-2-5871524283995-35-47141
-3-3-30-3-2-2-1-1-3-12-9-3-1-6-2-2-2-3-3-4-4-6-9-28-48-63-10
00-110-500-24-247-3801636-3-50-2-2-7-6-8-96-17-19-14-52166
33-70-122-22-2311-26920382-4700-4-2-3-92-11-1014428476
0000000000000000000000000000
1100-1-100-1-19-10000-7000000-100-1-1
001101932481502-60037800-5030-1-396-1-2-1
001201822470491-6-1-137100-5-130-1-492-2-3-3
-2.00-2.00-----------------------3.00---
0000000000000000000000000000
-1-1003-2126-2022-1212735-1-496450115-3615-1285-44-32206
-4.72-4.72-4.29-0.3-13.74-8.02-2.871.461.936.544.051.88-6.3-1.49-2.72-5.5-7.395.934.5212.0320.2523.8232.750.49-23.11-83.5-111.11131.28
0000000000000000000000000000

OraSure Technologies stock margins

The OraSure Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of OraSure Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for OraSure Technologies.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the OraSure Technologies's sales revenue. A higher gross margin percentage indicates that the OraSure Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the OraSure Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the OraSure Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the OraSure Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the OraSure Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the OraSure Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

OraSure Technologies Margin History

OraSure Technologies Gross marginOraSure Technologies Profit marginOraSure Technologies EBIT marginOraSure Technologies Profit margin
2028e42.85 %3.75 %9.77 %
2027e42.85 %0 %-21.86 %
2026e42.85 %-34.88 %-31.88 %
2025e42.85 %-48.29 %-43.35 %
202442.85 %-12.62 %-10.49 %
202342.55 %11.66 %13.23 %
202238.09 %-1.57 %-4.62 %
202150.32 %-5.01 %-9.84 %
202059.35 %-2.8 %-8.68 %
201961.19 %5.05 %10.8 %
201862.52 %16.29 %11.23 %
201759.25 %16.58 %18.49 %
201668.64 %15.83 %15.37 %
201567.08 %6.77 %6.85 %
201462.54 %-9.67 %-4.32 %
201359.25 %-20.73 %-11.32 %
201263.33 %-18.56 %-17.2 %
201163.13 %-11.48 %-10.74 %
201063.2 %-4.53 %-4.67 %
200961.17 %-5.58 %-10.13 %
200857.81 %-22.93 %-44.02 %
200760.82 %-1.45 %3.02 %
200664.52 %8.94 %7.77 %
200559.65 %10.95 %39.48 %

OraSure Technologies Stock Sales Revenue, EBIT, Earnings per Share

The OraSure Technologies earnings per share therefore indicates how much revenue OraSure Technologies has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OraSure Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OraSure Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OraSure Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OraSure Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

OraSure Technologies Revenue, EBIT and net profit per share

DateOraSure Technologies Sales per ShareOraSure Technologies EBIT per shareOraSure Technologies Earnings per Share
2028e2.19 undefined0 undefined0.21 undefined
2027e2.03 undefined0 undefined-0.44 undefined
2026e1.87 undefined0 undefined-0.6 undefined
2025e1.75 undefined0 undefined-0.76 undefined
20242.5 undefined-0.32 undefined-0.26 undefined
20235.45 undefined0.64 undefined0.72 undefined
20225.34 undefined-0.08 undefined-0.25 undefined
20213.25 undefined-0.16 undefined-0.32 undefined
20202.54 undefined-0.07 undefined-0.22 undefined
20192.49 undefined0.13 undefined0.27 undefined
20182.91 undefined0.47 undefined0.33 undefined
20172.74 undefined0.45 undefined0.51 undefined
20162.27 undefined0.36 undefined0.35 undefined
20152.11 undefined0.14 undefined0.14 undefined
20141.91 undefined-0.18 undefined-0.08 undefined
20131.78 undefined-0.37 undefined-0.2 undefined
20121.7 undefined-0.32 undefined-0.29 undefined
20111.75 undefined-0.2 undefined-0.19 undefined
20101.62 undefined-0.07 undefined-0.08 undefined
20091.68 undefined-0.09 undefined-0.17 undefined
20081.53 undefined-0.35 undefined-0.67 undefined
20071.76 undefined-0.03 undefined0.05 undefined
20061.46 undefined0.13 undefined0.11 undefined
20051.51 undefined0.16 undefined0.59 undefined

OraSure Technologies business model

OraSure Technologies Inc. is a US company specializing in the development, manufacturing, and marketing of diagnostic medical products. It was founded in 1987 under the name SolarCare Technologies Corporation and changed its name to OraSure Technologies Inc. in 2000. The company's main goal is to reduce the prevalence of infectious diseases and improve global health. It focuses on four core areas: infectious diseases, microfluidic analysis, application management, and genomics. In the field of infectious diseases, OraSure Technologies Inc. produces various rapid tests for detecting diseases such as HIV, Hepatitis C, and Syphilis. It also offers tests for drug and alcohol consumption verification. In microfluidic analysis, the company produces devices and test kits for biomedical research and clinical use. These technologies allow for the quick analysis of small samples and accurate results. Application management is another important aspect of the company, offering cloud-based applications for optimized data and information management. These applications help businesses and institutions obtain real-time data and use data analytics tools. Additionally, OraSure Technologies Inc. is involved in genomics and offers various products and services related to DNA sequencing. The company has a broad customer base, ranging from government agencies and research institutions to service companies and private clinics. It operates in numerous countries worldwide. An example of a product from OraSure Technologies is the OraQuick HIV self-test, which allows individuals to determine within 20 minutes whether they are infected with the HIV virus or not. This is particularly important for people who cannot or do not want to visit a doctor and value their privacy. OraSure Technologies' history is marked by numerous innovations and significant milestones. One notable event was the development of the first oral HIV rapid test in 2004, which allowed for quick and reliable detection of the virus through a saliva sample instead of a blood sample. In recent years, the company has increased its investment in research and development and formed partnerships with companies and institutions to bring innovative diagnostic medical products to the market. In summary, OraSure Technologies Inc. is a leading US company specializing in the development, manufacturing, and marketing of diagnostic medical products. With a focus on infectious diseases, microfluidic analysis, application management, and genomics, the company has a wide range of products and a broad customer base. OraSure Technologies is an innovative company striving to improve global health through partnerships and investments in research and development. OraSure Technologies is one of the most popular companies on Eulerpool.com.

OraSure Technologies SWOT Analysis

Strengths

OraSure Technologies Inc has several strengths that contribute to its success in the market. One notable strength is its strong product portfolio, which includes a range of innovative diagnostic tests and specimen collection devices. These products are highly reliable and have approval from regulatory authorities, offering customers confidence in their effectiveness.

Another strength is OraSure's commitment to research and development. By continually investing in new technologies and product improvements, the company stays ahead of the competition and can meet the evolving needs of the healthcare industry.

Weaknesses

Despite its strengths, OraSure Technologies Inc also faces some weaknesses. One significant weakness is its limited market presence outside of certain geographic regions. While the company enjoys strong brand recognition in certain markets, expanding its reach to new regions presents a challenge.

Additionally, OraSure relies on a few key customers for a significant portion of its revenue. This dependence on a few major clients exposes the company to potential risks if these customers were to reduce their orders or switch to competitors.

Opportunities

OraSure Technologies Inc has several opportunities to capitalize on in the market. One key opportunity is the growing demand for point-of-care diagnostic tests and their potential integration with telemedicine. By focusing on developing user-friendly and accurate point-of-care solutions, the company can tap into this expanding market segment.

Another opportunity lies in strategic partnerships and collaborations. By joining forces with other healthcare organizations or technology companies, OraSure can leverage complementary expertise and resources to enhance its product capabilities and enter new markets.

Threats

OraSure Technologies Inc faces various threats that could hinder its growth and market position. One significant threat is intense competition from both established players and emerging companies. To stay competitive, OraSure must continue to invest in research and development to differentiate itself and maintain its edge in the market.

Additionally, regulatory challenges and compliance requirements pose a threat to OraSure's operations. Changes in regulations or failure to comply with existing regulations could result in delays, increased costs, or the withdrawal of product approvals.

OraSure Technologies Revenue by Segment

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OraSure Technologies Revenue by Segment

Segmente20222021202020192018
Products and services-226.9 M USD166.38 M USD148.07 M USD-
Products and Services378.05 M USD----
Other revenues-6.78 M USD5.34 M USD6.53 M USD-
Other Revenues9.43 M USD----
Other-----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OraSure Technologies Revenue by Segment

Segmente20222021202020192018
COVID-19243.33 M USD----
Product----165.43 M USD
Genomics54.34 M USD----
HIV [ Member ]38.81 M USD----
HCV [ Member ]13.37 M USD----
Risk Assessment Testing10.27 M USD----
Royalty----9.65 M USD
Microbiome7.5 M USD----
Laboratory Services7.3 M USD----
Other Non Product Revenues6.75 M USD----
Other revenues----6.66 M USD
Other Product And Services Revenues3.14 M USD----
Royalty Income2.68 M USD----
COVID-19 (1)-----
HCV-----
HIV-----
Molecular Sample Management Solutions (2)-----
Molecular Services-----
Non-product and services revenues-----
Other product and services revenues-----
Risk assessment testing-----

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OraSure Technologies Revenue by Segment

Segmente20222021202020192018
COVID-19-76.87 M USD49.8 M USD--
Infectious disease testing-54.65 M USD54.23 M USD--
Genomics-63.35 M USD37.14 M USD--
Oraquick---56.06 M USD-
Oragene---46.7 M USD-
Laboratory services-11.84 M USD9.56 M USD--
Risk assessment testing-9.68 M USD9.37 M USD--
Microbiome-7.94 M USD6.16 M USD--
Royalty income-4.42 M USD3.43 M USD5.12 M USD-
ORAcollect---10.65 M USD-
Other products---9.52 M USD-
Intercept---8.11 M USD-
Microbiome laboratory services---6.1 M USD-
Histofreezer---5.7 M USD-
OMNIgene® • GUT---5.23 M USD-
Other non product revenues-2.36 M USD1.91 M USD--
Other Product and Services Revenues-2.57 M USD---
Government Contract2.25 M USD----
Research and development funding---851,000 USD-
Grant funding---304,000 USD-
Charitable support reimbursement---261,000 USD-
Other product revenue--117,000 USD--

  • 3 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OraSure Technologies Revenue by Segment

Segmente20222021202020192018
Government Contract-561,000 USD---

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

OraSure Technologies Revenue by Segment

Segmente20222021202020192018
Diagnostics303.67 M USD90.04 M USD65.24 M USD--
Molecular solutions-143.63 M USD106.48 M USD--
DNAG---76.38 M USD96.11 M USD
OSUR---78.23 M USD85.64 M USD
Molecular Solutions83.81 M USD----

OraSure Technologies Revenue by Region

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

OraSure Technologies Revenue by Segment

DateEuropeOther foreign countriesOther regionsOther RegionsUnited States
20238.11 M USD-35.7 M USD-361.66 M USD
202211.54 M USD--25.74 M USD350.21 M USD
202113.8 M USD31.49 M USD--188.38 M USD
202012.07 M USD28.82 M USD--130.84 M USD
201911.75 M USD35.57 M USD--107.28 M USD
201811.06 M USD33.83 M USD--136.85 M USD
Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

OraSure Technologies Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

OraSure Technologies historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

OraSure Technologies shares outstanding

The number of shares was OraSure Technologies in 2024 — This indicates how many shares 74.434 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue OraSure Technologies earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates OraSure Technologies's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of OraSure Technologies’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating OraSure Technologies's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for OraSure Technologies.

OraSure Technologies latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
3/31/2025-0.21 -0.21  (-0.43 %)2025 Q1
12/31/2024-0.06 -0.14  (-142.21 %)2024 Q4
9/30/2024-0.08 -0.06  (23.27 %)2024 Q3
6/30/2024-0.03 -0.01  (67.32 %)2024 Q2
3/31/20240.01 -0.05  (-749.35 %)2024 Q1
12/31/20230.09 0.27  (211.42 %)2023 Q4
9/30/20230.04 0.15  (267.65 %)2023 Q3
6/30/2023-0.08 0.09  (215.09 %)2023 Q2
3/31/20230.14 0.37  (165.42 %)2023 Q1
12/31/2022-0.01 0.21  (2,158.82 %)2022 Q4
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the OraSure Technologies stock

Eulerpool World ESG Rating (EESG©)

51/ 100

🌱 Environment

40

👫 Social

82

🏛️ Governance

30

Environment

Scope 1 - Direct Emissions
1,148
Scope 2 - Indirect emissions from purchased energy
1,944
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
3,091
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees57
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

OraSure Technologies shareholders

%
Name
Stocks
Change
Date
7.49117 % BlackRock Institutional Trust Company, N.A.5,575,97627,4803/31/2025
5.93442 % Private Management Group, Inc.4,417,2274,417,2273/31/2025
5.76300 % The Vanguard Group, Inc.4,289,63160,9713/31/2025
5.75149 % Neuberger Berman, LLC4,281,067653,0173/31/2025
5.13491 % Dimensional Fund Advisors, L.P.3,822,116-147,5643/31/2025
3.70162 % Acadian Asset Management LLC2,755,266-144,4523/31/2025
3.45426 % Renaissance Technologies LLC2,571,143-203,3003/31/2025
3.36556 % American Century Investment Management, Inc.2,505,124159,2873/31/2025
2.45966 % Eglinton (Manner Carrie)1,830,827142,4616/4/2025
2.36050 % Geode Capital Management, L.L.C.1,757,017-87,1223/31/2025
1
2
3
4
5
...
10

OraSure Technologies Executives and Management Board

Ms. Carrie Eglinton Manner

(50)
OraSure Technologies President, Chief Executive Officer, Director (since 2022)
Compensation 6.7 M

Ms. Kathleen Weber

(57)
OraSure Technologies Chief Product Officer
Compensation 1.67 M

Mr. Kenneth Mcgrath

(52)
OraSure Technologies Chief Financial Officer
Compensation 1.53 M

Ms. Mara Aspinall

(61)
OraSure Technologies Independent Chairman of the Board
Compensation 228,992

Mr. James Datin

(60)
OraSure Technologies Independent Director
Compensation 185,000
1
2
3

Most common questions regarding OraSure Technologies

What values and corporate philosophy does OraSure Technologies represent?

OraSure Technologies Inc represents core values of innovation, integrity, and excellence. With a strong corporate philosophy, the company strives to make a positive impact on healthcare by developing and providing innovative diagnostic tests and specimen collection devices. OraSure Technologies Inc is dedicated to improving public health outcomes through its commitment to quality, accuracy, and reliability. Through cutting-edge technologies and a focus on customer satisfaction, the company has become a leader in the industry, delivering accurate and rapid diagnostic solutions. OraSure Technologies Inc's dedication to constant innovation and maintaining the highest standards makes it a trusted name in the healthcare sector.

In which countries and regions is OraSure Technologies primarily present?

OraSure Technologies Inc is primarily present in the United States.

What significant milestones has the company OraSure Technologies achieved?

OraSure Technologies Inc has achieved several significant milestones. One of the notable achievements is the development and FDA approval of the OraQuick® In-Home HIV Test, which is the first rapid HIV test that can be used by individuals in the comfort of their own homes. This groundbreaking product has helped to increase HIV testing rates and improve early detection. Additionally, OraSure Technologies Inc has made significant strides in the field of oral fluid diagnostics, paving the way for advancements in drug testing and healthcare diagnostics. The company continues to innovate and collaborate with industry partners, solidifying its position as a leader in the diagnostic testing space.

What is the history and background of the company OraSure Technologies?

OraSure Technologies Inc. is a leading global provider of diagnostic testing and specimen collection devices. Founded in 1987, the company has a rich history of developing innovative solutions for infectious diseases and substance abuse testing. OraSure Technologies Inc. is focused on improving public health by offering non-invasive testing options that are accurate, reliable, and user-friendly. With a diverse portfolio of products, including the OraQuick® In-Home HIV Test and the OraCollect™ DNA Device, the company aims to empower individuals and healthcare professionals with effective tools for early detection and prevention. OraSure Technologies Inc. continues to drive advancements in diagnostics, making a significant impact on the healthcare industry.

Who are the main competitors of OraSure Technologies in the market?

The main competitors of OraSure Technologies Inc in the market are Abbott Laboratories, Quidel Corporation, and Hologic, Inc.

In which industries is OraSure Technologies primarily active?

OraSure Technologies Inc is primarily active in the biotechnology and healthcare industries.

What is the business model of OraSure Technologies?

OraSure Technologies Inc. operates under a diversified business model. The company specializes in the development, manufacturing, and distribution of point-of-care diagnostic and specimen collection devices. OraSure's products serve various industries, including healthcare, criminal justice, drug treatment, and public health. With a focus on innovative technologies, OraSure delivers solutions for rapid diagnostic testing, such as HIV and hepatitis C detection. The company also offers oral fluid collection devices for DNA testing and substance abuse monitoring. Through its comprehensive business model, OraSure Technologies Inc. remains committed to enhancing healthcare outcomes and improving overall testing processes.

What is the P/E ratio of OraSure Technologies 2025?

The P/E ratio cannot be calculated for OraSure Technologies at the moment.

What is the P/S ratio of OraSure Technologies 2025?

The P/S cannot be calculated for OraSure Technologies currently.

What is the Quality Investing of OraSure Technologies?

The Quality Investing for OraSure Technologies is 3/10.

What is the revenue of OraSure Technologies 2025?

The expected OraSure Technologies revenue is 130.47 M USD.

How high is the profit of OraSure Technologies 2025?

The expected OraSure Technologies profit is -56.56 M USD.

What is the business model of OraSure Technologies

OraSure Technologies Inc is a US company specializing in the development and marketing of diagnostic tests, devices, and medical accessories. It was founded in 2000 as a spin-off of Epitope Inc. Currently, OraSure Technologies Inc employs over 500 employees and is headquartered in Bethlehem, Pennsylvania. The company's business model is based on various divisions focusing on different medical applications. These include divisions such as "Infectious Diseases," "Clinical Laboratory Diagnostics," and "Molecular Diagnostics." In the Infectious Diseases division, OraSure Technologies Inc offers various tests for detecting infections, including the OraQuick® HCV Rapid Antibody Test, a test for the rapid and easy detection of Hepatitis C antibodies in the blood. The company also manufactures the OraQuick® HIV Self-Test and the OraQuick® In-Home HIV Test, which provide a simple and convenient way for patients to test themselves for HIV. The Clinical Laboratory Diagnostics division focuses on the development of diagnostic tests for use in clinical laboratories. OraSure Technologies Inc offers products such as the Intercept® i2F Body Fluid Collection Device and the Intercept® Oral Fluid Drug Test, which enable fast and reliable analysis of various body fluids. The Molecular Diagnostics division focuses on the development of molecular biological tests for detecting diseases based on DNA and RNA analysis. The company offers products such as the OraSure® OMNIgene® GUT Kit for stabilizing DNA samples and the OraQuick® Ebola Rapid Antigen Test, which allows for rapid and reliable detection of Ebola antigens. In addition to the development and marketing of diagnostic tests and devices, OraSure Technologies Inc also offers medical diagnostic accessories. These include the Intercept® Collection Kit and the OraSure® Sample Collection Device, which enable reliable and secure sample collection for blood tests and other examinations. OraSure Technologies Inc's business model is based on a strong focus on research and development of new products, as well as the safe and reliable production of diagnostic tests and devices for use in medical facilities. Through close collaboration with leading medical research institutes and universities, OraSure Technologies Inc is able to develop innovative and groundbreaking products for medical diagnostics, making an important contribution to healthcare and disease prevention.

What is the OraSure Technologies dividend?

OraSure Technologies pays a dividend of 0 USD distributed over payouts per year.

How often does OraSure Technologies pay dividends?

The dividend cannot currently be calculated for OraSure Technologies or the company does not pay out a dividend.

What is the OraSure Technologies ISIN?

The ISIN of OraSure Technologies is US68554V1089.

What is the OraSure Technologies WKN?

The WKN of OraSure Technologies is 881351.

What is the OraSure Technologies ticker?

The ticker of OraSure Technologies is OSUR.

How much dividend does OraSure Technologies pay?

Over the past 12 months, OraSure Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OraSure Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of OraSure Technologies?

The current dividend yield of OraSure Technologies is .

When does OraSure Technologies pay dividends?

OraSure Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of OraSure Technologies?

OraSure Technologies paid dividends every year for the past 0 years.

What is the dividend of OraSure Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is OraSure Technologies located?

OraSure Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von OraSure Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of OraSure Technologies from 7/27/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/27/2025.

When did OraSure Technologies pay the last dividend?

The last dividend was paid out on 7/27/2025.

What was the dividend of OraSure Technologies in the year 2024?

In the year 2024, OraSure Technologies distributed 0 USD as dividends.

In which currency does OraSure Technologies pay out the dividend?

The dividends of OraSure Technologies are distributed in USD.

All fundamentals about OraSure Technologies

Our stock analysis for OraSure Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OraSure Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.